Wolverine Asset Management »

Trisalus Life Sciences shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $240k 44k 5.52
2023-09-30 $2.1k 415 5.12

More positions owned by Wolverine Asset Management

Ati Note 3.500% 6/1 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Rivian Automotive Com Cl A Put Option (RIVN)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Draftkings Note 3/1 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Sea Note 2.375%12/0 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)
Airbnb Note 3/1 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Snap Note 0.125% 3/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Zto Express Cayman Note 1.500% 9/0 (Principal)
Enphase Energy Note 3/0 (Principal)

View all positions for Wolverine Asset Management

Top funds holding Trisalus Life Sciences

Duquesne Family Office
Vanguard Group
Highbridge Capital Management
Exos Asset Management
Geode Capital Management
Millennium Management
Lido Advisors
Wolverine Asset Management
Hrt Financial
Connecticut Wealth Management
BlackRock
Goldman Sachs Group
Cambridge Investment Research Advisors
State Street Corporation
Tower Research Capital

View all funds holding Trisalus Life Sciences